{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:05:58Z","timestamp":1791349558476,"version":"4.3.1"},"reference-count":177,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1053\/j.seminhematol.2022.02.005","type":"journal-article","created":{"date-parts":[[2022,2,20]],"date-time":"2022-02-20T09:38:35Z","timestamp":1645349915000},"page":"59-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Platelet-activating anti-PF4 disorders: An overview"],"prefix":"10.1053","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8046-7588","authenticated-orcid":false,"given":"Theodore E.","family":"Warkentin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.seminhematol.2022.02.005_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0037-1614206","article-title":"Heparin-induced thrombocytopenia: towards consensus","volume":"79","author":"Warkentin","year":"1998","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.02.005_bib0002","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/ijlh.12993","article-title":"Laboratory diagnosis of heparin-induced thrombocytopenia","volume":"41","author":"Warkentin","year":"2019","journal-title":"Int J Lab Hematol"},{"issue":"10","key":"10.1053\/j.seminhematol.2022.02.005_bib0003","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1182\/blood.V97.10.3300","article-title":"Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia","volume":"97","author":"Pouplard","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2022.02.005_bib0004","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1182\/blood.V98.4.1252","article-title":"Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8","volume":"98","author":"Arepally","year":"2001","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2022.02.005_bib0005","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1160\/TH16-02-0162","article-title":"Role of monocytes and endothelial cells in heparin-induced thrombocytopenia","volume":"116","author":"Madeeva","year":"2016","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1053\/j.seminhematol.2022.02.005_bib0006","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1160\/TH03-10-0649","article-title":"Polymorphonuclear leukocyte and monocyte activation induced by plasma from patients with heparin-induced thrombocytopenia in whole blood","volume":"92","author":"Khairy","year":"2004","journal-title":"Thromb Haemost"},{"issue":"18","key":"10.1053\/j.seminhematol.2022.02.005_bib0007","doi-asserted-by":"crossref","first-page":"e99445","DOI":"10.1172\/jci.insight.99445","article-title":"Neutrophil accumulation and NET release contribute to thrombosis in HIT","volume":"3","author":"Golomp","year":"2018","journal-title":"JCI Insight"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.02.005_bib0008","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41467-019-09160-7","article-title":"Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia","volume":"10","author":"Perdomo","year":"2019","journal-title":"Nat Commun"},{"issue":"23","key":"10.1053\/j.seminhematol.2022.02.005_bib0009","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1182\/bloodadvances.2020003093","article-title":"Inhibition of NADPH oxidase blocks NETosis and reduces thrombosis in heparin-induced thrombocytopenia","volume":"5","author":"Leung","year":"2021","journal-title":"Blood Adv"},{"issue":"10","key":"10.1053\/j.seminhematol.2022.02.005_bib0010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM198703053161004","article-title":"Immune endothelial-cell injury in heparin-associated thrombocytopenia","volume":"316","author":"Cines","year":"1987","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.seminhematol.2022.02.005_bib0011","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1172\/JCI90958","article-title":"Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia","volume":"127","author":"Hayes","year":"2017","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1053\/j.seminhematol.2022.02.005_bib0012","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1182\/blood-2011-02-335208","article-title":"Antibodies associated with heparin-induced thrombocytopenia (HIT) inhibit activated protein C generation: new insights into the prothrombotic nature of HIT","volume":"118","author":"Kowalska","year":"2011","journal-title":"Blood"},{"issue":"15","key":"10.1053\/j.seminhematol.2022.02.005_bib0013","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1182\/blood.2018881607","article-title":"Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation","volume":"135","author":"Johnston","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2022.02.005_bib0014","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V72.3.925.bloodjournal723925","article-title":"Heparin-induced thrombocytopenia: laboratory studies","volume":"72","author":"Kelton","year":"1988","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2022.02.005_bib0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2141.1989.tb00258.x","article-title":"Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets","volume":"73","author":"Chong","year":"1989","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1053\/j.seminhematol.2022.02.005_bib0016","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/09537109975960","article-title":"Generation of platelet-derived microparticles and procoagulant activity by heparin-induced thrombocytopenia IgG\/serum and other IgG platelet agonists: a comparison with standard platelet agonists","volume":"10","author":"Warkentin","year":"1999","journal-title":"Platelets"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0017","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41420-019-0188-0","article-title":"Platelet factor 4-containing immune complexes induced platelet activation followed by calpain-dependent platelet death","volume":"5","author":"Nevzorova","year":"2019","journal-title":"Cell Death Discov"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0018","series-title":"Heparin-induced thrombocytopenia, 5th edn","first-page":"209","article-title":"Platelet and leukocyte Fc\u03b3 receptors in heparin-induced thrombocytopenia","author":"Denomme","year":"2013"},{"issue":"4","key":"10.1053\/j.seminhematol.2022.02.005_bib0019","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1365-2141.1993.tb03150.x","article-title":"Heparin-associated thrombocytopenia: immune complexes are attached to the platelet membrane by the negative charge of highly sulphated oligosaccharides","volume":"84","author":"Greinacher","year":"1993","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.02.005_bib0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/ijlh.13223","article-title":"Evolving concepts of pathogenesis of heparin-induced thrombocytopenia: diagnostic and therapeutic implications","volume":"42","author":"Chong","year":"2020","journal-title":"Int J Lab Hematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2022.02.005_bib0021","first-page":"371","article-title":"Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia","volume":"120","author":"Warkentin","year":"1992","journal-title":"J Lab Clin Med"},{"issue":"19","key":"10.1053\/j.seminhematol.2022.02.005_bib0022","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1182\/bloodadvances.2019000235","article-title":"Heterogeneity in neutrophil responses to immune complexes","volume":"3","author":"Duarte","year":"2019","journal-title":"Blood Adv"},{"issue":"4","key":"10.1053\/j.seminhematol.2022.02.005_bib0023","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2141.2003.04334.x","article-title":"Heparin-induced thrombocytopenia: pathogenesis and management","volume":"121","author":"Warkentin","year":"2003","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1053\/j.seminhematol.2022.02.005_bib0024","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMp068309","article-title":"Drug-induced immune-mediated thrombocytopenia\u2014from purpura to thrombosis","volume":"356","author":"Warkentin","year":"2007","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.seminhematol.2022.02.005_bib0025","first-page":"409","article-title":"Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations","volume":"136","author":"Rhodes","year":"1973","journal-title":"Surg Gynecol Obstet"},{"issue":"6","key":"10.1053\/j.seminhematol.2022.02.005_bib0026","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/00000658-197712000-00017","article-title":"Heparin induced thrombocytopenia: eight cases with thrombotic-hemorrhagic complications","volume":"186","author":"Rhodes","year":"1977","journal-title":"Ann Surg"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.02.005_bib0027","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0038-1656329","article-title":"Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia","volume":"68","author":"Amiral","year":"1992","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1053\/j.seminhematol.2022.02.005_bib0028","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1182\/blood.V83.11.3232.3232","article-title":"Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4","volume":"83","author":"Kelton","year":"1994","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2022.02.005_bib0029","first-page":"247","article-title":"Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen","volume":"71","author":"Greinacher","year":"1994","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.02.005_bib0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1172\/JCI116987","article-title":"Antibodies from patients with heparin-induced thrombocytopenia\/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells","volume":"93","author":"Visentin","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0031","series-title":"Heparin-Induced Thrombocytopenia, 5th edn","first-page":"164","article-title":"Role of heparin-dependent antigens in immune heparin-induced thrombocytopenia","author":"Amiral","year":"2013"},{"issue":"18","key":"10.1053\/j.seminhematol.2022.02.005_bib0032","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1016\/S0021-9258(17)39951-9","article-title":"Isolation, crystallization, and primary amino acid sequence of human platelet factor 4","volume":"252","author":"Hermodson","year":"1977","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1053\/j.seminhematol.2022.02.005_bib0033","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0049-3848(77)90117-7","article-title":"Primary structure of human platelet factor 4","volume":"11","author":"Walz","year":"1977","journal-title":"Thromb Res"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.02.005_bib0034","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V69.1.219.219","article-title":"Cloning and characterization of platelet factor 4 cDNA derived from a human erythroleukemic cell line","volume":"69","author":"Poncz","year":"1987","journal-title":"Blood"},{"issue":"1-2","key":"10.1053\/j.seminhematol.2022.02.005_bib0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000015209","article-title":"Physical mapping of the CXC chemokine locus on human chromosome 4","volume":"84","author":"O'Donovan","year":"1999","journal-title":"Cytogenet Cell Genet"},{"issue":"2","key":"10.1053\/j.seminhematol.2022.02.005_bib0036","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1042\/bj3120357","article-title":"Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: arginine residues are crucial for binding","volume":"312","author":"Mayo","year":"1995","journal-title":"Biochem J"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.02.005_bib0037","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1182\/blood-2004-04-1544","article-title":"Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia","volume":"105","author":"Rauova","year":"2005","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2022.02.005_bib0038","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/01.ATV.0000238350.89477.88","article-title":"Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies","volume":"26","author":"Greinacher","year":"2006","journal-title":"Arterioscler Thromb Vasc. Biol"},{"issue":"13","key":"10.1053\/j.seminhematol.2022.02.005_bib0039","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1182\/blood-2007-08-105098","article-title":"Determinants of PF4\/heparin immunogenicity","volume":"110","author":"Suvarna","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.02.005_bib0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood.V67.1.27.27","article-title":"A diagnostic test for heparin-induced thrombocytopenia","volume":"67","author":"Sheridan","year":"1986","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2022.02.005_bib0041","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1096-8652(199703)54:3<196::AID-AJH4>3.0.CO;2-R","article-title":"Characterization of the humoral immune response in heparin-induced thrombocytopenia","volume":"54","author":"Suh","year":"1997","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2022.02.005_bib0042","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood.V91.3.916","article-title":"Antibodies from patients with heparin-induced thrombocytopenia\/thrombosis recognize different epitopes on heparin:platelet factor 4","volume":"91","author":"Suh","year":"1998","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminhematol.2022.02.005_bib0043","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1182\/blood.V92.9.3250","article-title":"Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia","volume":"92","author":"Ziporen","year":"1998","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2022.02.005_bib0044","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1182\/blood.V99.4.1230","article-title":"Defining a second epitope for heparin-induced thrombocytopenia\/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody","volume":"99","author":"Li","year":"2002","journal-title":"Blood"},{"issue":"7873","key":"10.1053\/j.seminhematol.2022.02.005_bib0045","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"issue":"3","key":"10.1053\/j.seminhematol.2022.02.005_bib0046","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1055\/s-0040-1717078","article-title":"Characterization of new monoclonal PF4-specific antibodies as useful tools for studies on typical and autoimmune heparin-induced thrombocytopenia","volume":"121","author":"Vayne","year":"2021","journal-title":"Thromb Haemost"},{"issue":"17","key":"10.1053\/j.seminhematol.2022.02.005_bib0047","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJM200104263441704","article-title":"Temporal aspects of heparin-induced thrombocytopenia","volume":"344","author":"Warkentin","year":"2001","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1053\/j.seminhematol.2022.02.005_bib0048","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1182\/blood-2008-10-186064","article-title":"Studies of the immune response in heparin-induced thrombocytopenia","volume":"113","author":"Warkentin","year":"2009","journal-title":"Blood"},{"issue":"20","key":"10.1053\/j.seminhematol.2022.02.005_bib0049","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1182\/blood-2008-08-173062","article-title":"The temporal profile of the anti-PF4\/heparin immune response","volume":"113","author":"Greinacher","year":"2009","journal-title":"Blood"},{"issue":"14","key":"10.1053\/j.seminhematol.2022.02.005_bib0050","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1182\/blood-2016-04-709634","article-title":"The antigenic complex in HIT binds to B cells via complement and complement receptor 2 (CD21)","volume":"128","author":"Khandelwal","year":"2016","journal-title":"Blood"},{"issue":"23","key":"10.1053\/j.seminhematol.2022.02.005_bib0051","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1182\/blood-2018-03-834598","article-title":"Polyreactive IgM initiates complement activation by PF4\/heparin complexes through the classical pathway","volume":"132","author":"Khandelwal","year":"2018","journal-title":"Blood"},{"issue":"21","key":"10.1053\/j.seminhematol.2022.02.005_bib0052","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1182\/blood.2020009487","article-title":"Complement mediates binding and procoagulant effects of ultralarge HIT immune complexes","volume":"138","author":"Khandelwal","year":"2021","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2022.02.005_bib0053","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1182\/blood-2010-08-301424","article-title":"Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia","volume":"117","author":"Krauel","year":"2011","journal-title":"Blood"},{"issue":"16","key":"10.1053\/j.seminhematol.2022.02.005_bib0054","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1182\/blood-2012-06-434985","article-title":"Platelet factor 4 binding to lipid A of Gram-negative bacteria exposes PF4\/heparin-like epitopes","volume":"120","author":"Krauel","year":"2012","journal-title":"Blood"},{"issue":"20","key":"10.1053\/j.seminhematol.2022.02.005_bib0055","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1182\/blood-2013-11-540526","article-title":"Amplification of bacteria-induced platelet activation is triggered by Fc\u03b3RIIA, integrin \u03b1IIb\u03b23, and platelet factor 4","volume":"123","author":"Arman","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2022.02.005_bib0056","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1160\/TH15-01-0062","article-title":"Polyphosphates form antigenic complexes with platelet factor 4 (PF4) and enhance PF4-binding to bacteria","volume":"114","author":"Brandt","year":"2015","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1053\/j.seminhematol.2022.02.005_bib0057","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/jth.13955","article-title":"Platelets kill bacteria by bridging innate and adaptive immunity via platelet factor 4 and Fc\u03b3RIIA","volume":"16","author":"Palankar","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1053\/j.seminhematol.2022.02.005_bib0058","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.chom.2012.10.017","article-title":"Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials","volume":"12","author":"Love","year":"2012","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.02.005_bib0059","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/ATVBAHA.113.302236","article-title":"Modulation of protein C activation by histones, platelet factor 4, and heparinoids: new insights into activated protein C formation","volume":"34","author":"Kowalska","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1053\/j.seminhematol.2022.02.005_bib0060","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1378\/chest.13-0057","article-title":"Heparin-induced thrombocytopenia in medical surgical critical illness","volume":"144","author":"Warkentin","year":"2013","journal-title":"Chest"},{"issue":"11","key":"10.1053\/j.seminhematol.2022.02.005_bib0061","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/jth.14264","article-title":"Heparin-induced thrombocytopenia-associated thrombosis: from arterial to venous to venous limb gangrene","volume":"16","author":"Warkentin","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"9","key":"10.1053\/j.seminhematol.2022.02.005_bib0062","doi-asserted-by":"crossref","first-page":"804","DOI":"10.7326\/0003-4819-127-9-199711010-00005","article-title":"The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia","volume":"127","author":"Warkentin","year":"1997","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1053\/j.seminhematol.2022.02.005_bib0063","first-page":"576","article-title":"Heparin-induced thrombocytopenia","volume":"21","author":"Warkentin","year":"2015","journal-title":"Curr Opin Crit Care"},{"issue":"5","key":"10.1053\/j.seminhematol.2022.02.005_bib0064","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","article-title":"A 14-year study of heparin-induced thrombocytopenia","volume":"101","author":"Warkentin","year":"1996","journal-title":"Am J Med"},{"issue":"7","key":"10.1053\/j.seminhematol.2022.02.005_bib0065","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1055\/s-0040-1712957","article-title":"Comparative analysis of a French prospective series of 144 patients with heparin-induced thrombocytopenia (FRIGTIH) and the literature","volume":"120","author":"Gruel","year":"2020","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1053\/j.seminhematol.2022.02.005_bib0066","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1517\/14740330902778180","article-title":"Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes","volume":"8","author":"Warkentin","year":"2009","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"10.1053\/j.seminhematol.2022.02.005_bib0067","first-page":"148","article-title":"Laboratory diagnosis of immune heparin-induced thrombocytopenia","volume":"2","author":"Warkentin","year":"2003","journal-title":"Curr Hematol Rep"},{"issue":"4","key":"10.1053\/j.seminhematol.2022.02.005_bib0068","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","article-title":"Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings","volume":"4","author":"Lo","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1053\/j.seminhematol.2022.02.005_bib0069","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1055\/s-0038-1648491","article-title":"Heparin-associated thrombocytopenia: the antibody is not heparin specific","volume":"67","author":"Greinacher","year":"1992","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1053\/j.seminhematol.2022.02.005_bib0070","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2141.1992.tb08216.x","article-title":"Heparin-associated thrombocytopenia in a patient treated with polysulphated chondroitin sulphate: evidence for immunological crossreactivity between heparin and polysulphated glycosaminoglycan","volume":"81","author":"Greinacher","year":"1992","journal-title":"Br J Haematol"},{"issue":"23","key":"10.1053\/j.seminhematol.2022.02.005_bib0071","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa0803200","article-title":"Contaminated heparin associated with adverse clinical events and activation of the contact system","volume":"358","author":"Kishimoto","year":"2008","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1053\/j.seminhematol.2022.02.005_bib0072","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMc081387","article-title":"Contaminated heparin","volume":"359","author":"Greinacher","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.seminhematol.2022.02.005_bib0073","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-2141.1994.tb05120.x","article-title":"Pentosan-induced thrombocytopenia: support for an immune complex mechanism","volume":"88","author":"Goad","year":"1994","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1053\/j.seminhematol.2022.02.005_bib0074","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0750-7658(86)80044-2","article-title":"Thrombop\u00e9nie grave associ\u00e9e au traitement par polysulfate de pentosane","volume":"5","author":"Bollaert","year":"1986","journal-title":"Ann Fr Anesth R\u00e9anim"},{"issue":"3","key":"10.1053\/j.seminhematol.2022.02.005_bib0075","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ajh.2830450312","article-title":"Pentosan polysulfate-induced thrombocytopenia and thrombosis","volume":"45","author":"Tardy-Poncet","year":"1994","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1053\/j.seminhematol.2022.02.005_bib0076","first-page":"2148","article-title":"Pentosan induced cerebral sagittal sinus thrombosis: a variant of heparin induced thrombocytopenia","volume":"160","author":"Rice","year":"1998","journal-title":"J Urol"},{"issue":"5","key":"10.1053\/j.seminhematol.2022.02.005_bib0077","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/annonc\/mdf117","article-title":"Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia","volume":"13","author":"Rosenthal","year":"2002","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1053\/j.seminhematol.2022.02.005_bib0078","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1517\/13543784.17.11.1769","article-title":"PI-88: a novel inhibitor of angiogenesis","volume":"17","author":"Kudchadkar","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0079","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/978-3-030-34521-1_19","article-title":"PI-88 and related heparan sulfate mimetics","volume":"1221","author":"Chhabra","year":"2020","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1053\/j.seminhematol.2022.02.005_bib0080","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood-2013-01-478966","article-title":"Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4","volume":"122","author":"Jaax","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2022.02.005_bib0081","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1182\/blood-2013-05-504126","article-title":"HIT: nucleic acids masquerading as heparin","volume":"122","author":"Chong","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.02.005_bib0082","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1067\/mlc.2001.115525","article-title":"Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia\/thrombosis","volume":"138","author":"Visentin","year":"2001","journal-title":"J Lab Clin Med"},{"issue":"20","key":"10.1053\/j.seminhematol.2022.02.005_bib0083","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1053\/j.seminhematol.2022.02.005_bib0084","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/archinte.163.20.2518","article-title":"An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients","volume":"163","author":"Warkentin","year":"2003","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1053\/j.seminhematol.2022.02.005_bib0085","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","article-title":"Risk for heparin-induced thrombocytopenia with unfractionated heparin and low-molecular-weight heparin thromboprophylaxis: a meta-analysis","volume":"106","author":"Martel","year":"2005","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.seminhematol.2022.02.005_bib0086","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/jth.13813","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"15","author":"Greinacher","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.02.005_bib0087","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1182\/blood-2014-06-580894","article-title":"Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis","volume":"125","author":"Padmanabhan","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.02.005_bib0088","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/bloodadvances.2016000877","article-title":"Polyphosphate\/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia","volume":"1","author":"Cines","year":"2016","journal-title":"Blood Adv"},{"issue":"7","key":"10.1053\/j.seminhematol.2022.02.005_bib0089","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-135-7-200110020-00009","article-title":"Delayed-onset heparin-induced thrombocytopenia and thrombosis","volume":"135","author":"Warkentin","year":"2001","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1053\/j.seminhematol.2022.02.005_bib0090","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1056\/NEJM200303133481120","article-title":"Delayed-onset heparin-induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin","volume":"348","author":"Warkentin","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.seminhematol.2022.02.005_bib0091","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.hoc.2010.05.009","article-title":"Agents for the treatment of heparin-induced thrombocytopenia","volume":"24","author":"Warkentin","year":"2010","journal-title":"Hematol\/Oncol Clin N Am"},{"issue":"11","key":"10.1053\/j.seminhematol.2022.02.005_bib0092","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ajh.21273","article-title":"Delayed-onset heparin-induced thrombocytopenia caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis","volume":"83","author":"Alsaleh","year":"2008","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1053\/j.seminhematol.2022.02.005_bib0093","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/trf.15263","article-title":"Autoimmune heparin-induced thrombocytopenia and venous limb gangrene following aortic dissection repair: in vitro and in vivo effects of intravenous immunoglobulin","volume":"59","author":"Arcinas","year":"2019","journal-title":"Transfusion"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.02.005_bib0094","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1517\/14740338.2013.823946","article-title":"Anticoagulant failure in coagulopathic patients: PTT confounding and other pitfalls","volume":"13","author":"Warkentin","year":"2014","journal-title":"Exp Opin Drug Saf"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/asheducation-2011.1.143","article-title":"How I diagnose and manage HIT","volume":"2011","author":"Warkentin","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"5","key":"10.1053\/j.seminhematol.2022.02.005_bib0096","first-page":"813","article-title":"Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia","volume":"116","author":"Warkentin","year":"2016","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1053\/j.seminhematol.2022.02.005_bib0097","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.chest.2017.03.050","article-title":"IVIg for treatment of severe refractory heparin-induced thrombocytopenia","volume":"152","author":"Padmanabhan","year":"2017","journal-title":"Chest"},{"issue":"4","key":"10.1053\/j.seminhematol.2022.02.005_bib0098","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.transci.2018.06.007","article-title":"Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia","volume":"57","author":"Park","year":"2018","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"10.1053\/j.seminhematol.2022.02.005_bib0099","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1177\/1941874421995377","article-title":"Refractory heparin-induced thrombocytopenia in a patient with subarachnoid hemorrhage\u2014a clinical conundrum","volume":"11","author":"Newton","year":"2021","journal-title":"Neurohospitalist"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0100","series-title":"Heparin-induced thrombocytopenia, 5th edn","first-page":"24","article-title":"Clinical picture of heparin-induced thrombocytopenia","author":"Warkentin","year":"2013"},{"issue":"9","key":"10.1053\/j.seminhematol.2022.02.005_bib0101","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood-2017-04-778993","article-title":"Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review","volume":"130","author":"Warkentin","year":"2017","journal-title":"Blood"},{"issue":"14","key":"10.1053\/j.seminhematol.2022.02.005_bib0102","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1182\/blood-2017-06-788679","article-title":"Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma","volume":"130","author":"Mian","year":"2017","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2022.02.005_bib0103","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1182\/blood-2018-03-838672","article-title":"Heparin-induced thrombocytopenia and thrombosis during high dose melphalan and autologous stem cell transplantation","volume":"132","author":"Sarosiek","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.02.005_bib0104","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jca.21757","article-title":"Heparin-induced thrombocytopenia associated with collection of hematopoietic progenitor cells by apheresis","volume":"35","author":"Raval","year":"2020","journal-title":"J Clin Apher"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0105","article-title":"Successful use of intravenous immunoglobulin G to treat refractory heparin-induced thrombocytopenia with thrombosis complicating peripheral blood stem cell harvest","volume":"6","author":"McKenzie","year":"2018","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"5","key":"10.1053\/j.seminhematol.2022.02.005_bib0106","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1160\/TH07-06-0423","article-title":"Delayed-onset heparin-induced thrombocytopenia, venous thromboembolism, and cerebral venous thrombosis: a consequence of heparin \"flushes\"","volume":"98","author":"Refaai","year":"2007","journal-title":"Thromb Haemost"},{"issue":"25","key":"10.1053\/j.seminhematol.2022.02.005_bib0107","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1056\/NEJMc070346","article-title":"Heparin-induced thrombocytopenia associated with fondaparinux","volume":"356","author":"Warkentin","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1053\/j.seminhematol.2022.02.005_bib0108","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1160\/TH10-05-0284","article-title":"Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke","volume":"104","author":"Salem","year":"2010","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1053\/j.seminhematol.2022.02.005_bib0109","first-page":"394","article-title":"The serological profile of fondaparinux-associated heparin-induced thrombocytopenia syndrome","volume":"108","author":"Warkentin","year":"2012","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1053\/j.seminhematol.2022.02.005_bib0110","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1378\/chest.10-1599","article-title":"Prevalence and risk of preexisting heparin-induced thrombocytopenia antibodies in patients with acute VTE","volume":"140","author":"Warkentin","year":"2011","journal-title":"Chest"},{"issue":"5","key":"10.1053\/j.seminhematol.2022.02.005_bib0111","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1586\/ehm.10.54","article-title":"Fondaparinux: does it cause HIT? can it treat HIT?","volume":"3","author":"Warkentin","year":"2010","journal-title":"Exp Rev Hematol"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0112","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2021.05.018","article-title":"Spontaneous HIT syndrome: knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia","volume":"204","author":"Warkentin","year":"2021","journal-title":"Thromb Res"},{"issue":"9","key":"10.1053\/j.seminhematol.2022.02.005_bib0113","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1538-7836.2008.03040.x","article-title":"Fatal heparin-induced thrombocytopenia (HIT) during warfarin thromboprophylaxis following orthopedic surgery: another example of 'spontaneous' HIT?","volume":"6","author":"Jay","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1053\/j.seminhematol.2022.02.005_bib0114","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.amjmed.2008.03.012","article-title":"A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia","volume":"121","author":"Warkentin","year":"2008","journal-title":"Am J Med"},{"issue":"3","key":"10.1053\/j.seminhematol.2022.02.005_bib0115","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1538-7836.2008.03263.x","article-title":"Heparin-induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery \u2018spontaneous\u2019 HIT?","volume":"7","author":"Pruthi","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.02.005_bib0116","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MBC.0b013e328340ff11","article-title":"A patient with \u2018spontaneous\u2019 heparin-induced thrombocytopenia and thrombosis after undergoing knee replacement","volume":"22","author":"Mallik","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"4","key":"10.1053\/j.seminhematol.2022.02.005_bib0117","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1160\/TH12-11-0865","article-title":"Adrenal haemorrhage due to heparin-induced thrombocytopenia","volume":"109","author":"Ketha","year":"2013","journal-title":"Thromb Haemost"},{"issue":"23","key":"10.1053\/j.seminhematol.2022.02.005_bib0118","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1182\/blood-2014-01-549741","article-title":"Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder","volume":"123","author":"Warkentin","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2022.02.005_bib0119","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMc1414161","article-title":"Heparin-induced thrombocytopenia presenting as bilateral adrenal hemorrhages","volume":"372","author":"Warkentin","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.seminhematol.2022.02.005_bib0120","article-title":"Bilateral adrenal hemorrhage presenting with delayed adrenal crisis in a patient on rivaroxaban (Xaeralto) [sic]","volume":"36","author":"Machhadieh","year":"2015","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1053\/j.seminhematol.2022.02.005_bib0121","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.artd.2015.07.003","article-title":"Spontaneous heparin-induced thrombocytopenia presenting as bilateral adrenal hemorrhages and pulmonary embolism after total knee arthroplasty","volume":"1","author":"Elshoury","year":"2015","journal-title":"Arthroplast Today"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0122","article-title":"Spontaneous heparin-induced thrombocytopenia and venous thromboembolism following total knee arthroplasty","author":"Baker","year":"2017","journal-title":"Case Rep Hematol"},{"issue":"6","key":"10.1053\/j.seminhematol.2022.02.005_bib0123","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/09537104.2017.1366973","article-title":"Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review","volume":"28","author":"Poudel","year":"2017","journal-title":"Platelets"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0124","article-title":"Spontaneous HIT syndrome","volume":"5","author":"McCarthy","year":"2018","journal-title":"ACP Hospitalist"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.02.005_bib0125","first-page":"e70","article-title":"Adrenal insufficiency from unilateral hemorrhage in a patient on rivaroxaban thromboprophylaxis","volume":"5","author":"Ly","year":"2019","journal-title":"AACE Clin Case Rep"},{"issue":"5","key":"10.1053\/j.seminhematol.2022.02.005_bib0126","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/jth.14411","article-title":"High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome","volume":"17","author":"Mohanty","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0127","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.12659\/AJCR.917780","article-title":"Rivaroxaban related bilateral adrenal hemorrhage: a rare complications of direct oral anticoagulants \u2013 a case reports","volume":"20","author":"Alidoost","year":"2019","journal-title":"Am J Case Rep"},{"issue":"12","key":"10.1053\/j.seminhematol.2022.02.005_bib0128","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-232769","article-title":"Spontaneous heparin-induced thrombocytopenia syndrome presenting as bilateral adrenal infarction after knee arthroplasty","volume":"12","author":"VanderVeer","year":"2019","journal-title":"BMJ Case Rep"},{"issue":"11","key":"10.1053\/j.seminhematol.2022.02.005_bib0129","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1016\/S0735-1097(20)33806-7","article-title":"Spontaneous heparin induced thrombocytopenia: when a post-op pulmonary embolism isn't just a post-op pulmonary embolism","volume":"75","author":"Hornick","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.thromres.2020.08.009","article-title":"Spontaneous heparin induced thrombocytopenia (HIT) following curettage and bone graft of femur in a patient with monostotic fibrous dysplasia","volume":"196","author":"Swarup","year":"2020","journal-title":"Thromb Res"},{"issue":"7","key":"10.1053\/j.seminhematol.2022.02.005_bib0131","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1080\/09537104.2020.1828574","article-title":"Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty","volume":"32","author":"Hwang","year":"2021","journal-title":"Platelets"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0132","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.artd.2021.03.005","article-title":"Spontaneous\u201d heparin-induced thrombocytopenia and thrombosis after total knee arthroplasty: a report of 2 cases","volume":"9","author":"Olevsky","year":"2021","journal-title":"J Arthroplasty"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0133","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-245385","article-title":"Spontaneous heparin-induced thrombocytopaenia with adrenal haemorrhage following orthopaedic surgery: a case report and literature review","volume":"14","author":"Saengboon","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"6","key":"10.1053\/j.seminhematol.2022.02.005_bib0134","first-page":"725","article-title":"Anticorps anti-PF4 et thrombop\u00e9nie chez un enfant avec thrombophl\u00e9bite c\u00e9r\u00e9brale","volume":"68","author":"Desprez","year":"2010","journal-title":"Ann Biol Clin"},{"issue":"6","key":"10.1053\/j.seminhematol.2022.02.005_bib0135","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/09537104.2011.650245","article-title":"Rapid-onset heparin-induced thrombocytopenia without previous heparin exposure","volume":"23","author":"Olah","year":"2012","journal-title":"Platelets"},{"issue":"4","key":"10.1053\/j.seminhematol.2022.02.005_bib0136","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1160\/TH11-12-0825","article-title":"Rapid onset heparin-induced thrombocytopenia (HIT) without history of heparin exposure: a new case of so-called \u2018spontaneous\u2019 HIT","volume":"107","author":"Perrin","year":"2012","journal-title":"Thromb Haemost"},{"issue":"23","key":"10.1053\/j.seminhematol.2022.02.005_bib0137","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1182\/blood-2014-04-566836","article-title":"Me or not me? The danger of spontaneity","volume":"123","author":"Greinacher","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2022.02.005_bib0138","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3109\/09537104.2014.979338","article-title":"Spontaneous heparin-induced thrombocytopenia syndrome without any proximate heparin exposure, infection, or inflammatory condition: atypical clinical features with heparin-dependent platelet activating properties","volume":"26","author":"Okata","year":"2015","journal-title":"Platelets"},{"issue":"3","key":"10.1053\/j.seminhematol.2022.02.005_bib0139","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/trf.15105","article-title":"Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia","volume":"59","author":"Irani","year":"2019","journal-title":"Transfusion"},{"issue":"6","key":"10.1053\/j.seminhematol.2022.02.005_bib0140","doi-asserted-by":"crossref","first-page":"e929","DOI":"10.1212\/CPJ.0000000000000805","article-title":"Spontaneous heparin-induced thrombocytopenia presenting as cerebral venous sinus thrombosis","volume":"11","author":"Moores","year":"2021","journal-title":"Neurol Clin Pract"},{"issue":"6","key":"10.1053\/j.seminhematol.2022.02.005_bib0141","doi-asserted-by":"crossref","first-page":"e918","DOI":"10.1212\/CPJ.0000000000001026","article-title":"Spontaneous heparin-induced thrombocytopenia presenting as acute ischemic stroke","volume":"11","author":"Becker","year":"2021","journal-title":"Neurol Clin Pract"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0142","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-243315","article-title":"Autoimmune heparin-induced thrombocytopenia: a rare manifestation of COVID-19","volume":"14","author":"Julian","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0143","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-244143","article-title":"Multi-territorial strokes in the setting of autoimmune heparin-induced thrombocytopaenic thrombotic syndrome","author":"Kwan","year":"2022","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.02.005_bib0144","first-page":"1355","article-title":"Isolation of a monoclonal IgG kappa with functional autoantibody activity against platelet factor 4\/heparin from a patient with a monoclonal gammopathy of undetermined significance and clinically overt heparin thrombocytopenia [Conference Abstract]","volume":"1","author":"Faille","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0145","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2021.280366","article-title":"Platelet-activating anti-PF4 antibodies mimicking VITT antibodies in an unvaccinated patient with monoclonal gammopathy","author":"Greinacher","year":"2021","journal-title":"Haematologica"},{"issue":"22","key":"10.1053\/j.seminhematol.2022.02.005_bib0146","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1053\/j.seminhematol.2022.02.005_bib0147","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1053\/j.seminhematol.2022.02.005_bib0148","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1053\/j.seminhematol.2022.02.005_bib0149","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0150","article-title":"Case series of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination\u2014United States","author":"See","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0151","doi-asserted-by":"crossref","DOI":"10.7326\/M22-0118","article-title":"The epidemiology of thrombosis with thrombocytopenia syndrome: analogies with heparin-induced thrombocytopenia","author":"Warkentin","year":"2022","journal-title":"Ann Intern Med"},{"issue":"22","key":"10.1053\/j.seminhematol.2022.02.005_bib0152","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1182\/blood.2021013231","article-title":"Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia","volume":"138","author":"Greinacher","year":"2021","journal-title":"Blood"},{"issue":"49","key":"10.1053\/j.seminhematol.2022.02.005_bib0153","doi-asserted-by":"crossref","first-page":"eabl8213","DOI":"10.1126\/sciadv.abl8213","article-title":"ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome","volume":"7","author":"Baker","year":"2021","journal-title":"Sci Adv"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0154","doi-asserted-by":"crossref","unstructured":"Michalik S, Siegerist F, Palankar R, et al. Comparative analysis of ChAdOx1 nCoV-19 and Ad.26.COV2.S SARS-CoV-2 vector vaccines. Haematologica. 2022 Jan 20. doi: 10.3324\/haematol.2021.280154. Online ahead of print.","DOI":"10.21203\/rs.3.rs-736157\/v1"},{"issue":"14","key":"10.1053\/j.seminhematol.2022.02.005_bib0155","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/blood.2021012938","article-title":"Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein","volume":"138","author":"Greinacher","year":"2021","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0156","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.932946","article-title":"A 59-year-old woman with extensive deep vein thrombosis and pulmonary thromboembolism 7 days following a first dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine","volume":"22","author":"Al-Maqbali","year":"2021","journal-title":"Am J Case Rep"},{"issue":"10","key":"10.1053\/j.seminhematol.2022.02.005_bib0157","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.7326\/L21-0244","article-title":"Thrombosis with thrombocytopenia after the messenger RNA-1273 vaccine","volume":"174","author":"Sangli","year":"2021","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1053\/j.seminhematol.2022.02.005_bib0158","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.7326\/M21-2680","article-title":"Thrombosis after vaccination with messenger RNA-1273: is this vaccine-induced thrombosis and thrombocytopenia or thrombosis with thrombocytopenia syndrome?","volume":"174","author":"Pishko","year":"2021","journal-title":"Ann Intern Med"},{"issue":"39","key":"10.1053\/j.seminhematol.2022.02.005_bib0159","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1093\/eurheartj\/ehab506","article-title":"Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia","volume":"42","author":"Holm","year":"2021","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1053\/j.seminhematol.2022.02.005_bib0160","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1055\/a-1535-9002","article-title":"PF4-dependent immunoassays in patients with vaccine-induced immune thrombotic thrombocytopenia: results of an interlaboratory comparison","volume":"121","author":"Sachs","year":"2021","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1053\/j.seminhematol.2022.02.005_bib0161","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1055\/a-1585-6264","article-title":"Heparin-induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia antibodies: fraternal\u2014not identical\u2014twins","volume":"121","author":"Warkentin","year":"2021","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.02.005_bib0162","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ajh.25660","article-title":"Serotonin-release assay-negative heparin-induced thrombocytopenia","volume":"95","author":"Warkentin","year":"2020","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1053\/j.seminhematol.2022.02.005_bib0163","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa2107051","article-title":"Adjunct immune globulin for vaccine-induced immune thrombotic thrombocytopenia","volume":"385","author":"Bourguignon","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.seminhematol.2022.02.005_bib0164","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1056\/NEJMc2106383","article-title":"PF4 immunoassays in vaccine-induced thrombotic thrombocytopenia","volume":"385","author":"Vayne","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.seminhematol.2022.02.005_bib0165","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"22","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"issue":"22","key":"10.1053\/j.seminhematol.2022.02.005_bib0166","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMc2112974","article-title":"Vaccine-induced thrombocytopenia with severe headache","volume":"385","author":"Salih","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0167","article-title":"Heterogeneity of vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination and safety of second vaccination with BNT162b2","author":"Lindhoff-Last","year":"2021","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1053\/j.seminhematol.2022.02.005_bib0168","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1160\/TH17-03-0212","article-title":"Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review","volume":"117","author":"Shih","year":"2017","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1053\/j.seminhematol.2022.02.005_bib0169","first-page":"1076","article-title":"Antithrombin-independent thrombin inhibitors, but not direct factor Xa inhibitors, enhance thrombin generation in plasma through inhibition of thrombin-thrombomodulin-protein C system","volume":"106","author":"Furugohri","year":"2011","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.02.005_bib0170","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/jth.15572","article-title":"Vaccine-induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources","volume":"20","author":"Greinacher","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0171","series-title":"Hemostasis and thrombosis: basic principles and clinical practice, 6th edn","first-page":"1308","article-title":"Coumarin-induced skin necrosis and venous limb gangrene","author":"Warkentin","year":"2013"},{"issue":"4","key":"10.1053\/j.seminhematol.2022.02.005_bib0172","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1182\/blood-2015-01-622787","article-title":"Warfarin-induced venous limb ischemia\/gangrene complicating cancer: a novel and clinically distinct syndrome","volume":"126","author":"Warkentin","year":"2015","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.seminhematol.2022.02.005_bib0173","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/17474086.2019.1636645","article-title":"High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review","volume":"12","author":"Warkentin","year":"2019","journal-title":"Exp Rev Hematol"},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0174","unstructured":"Warkentin TE, Cuker A. COVID-19: Vaccine-induced immune thrombotic thrombocytopenia (VITT). UpToDate; 2021. Available: https:\/\/www.uptodate.com\/contents\/covid-19-vaccine-induced-immune-thrombotic-thrombocytopenia-vitt (accessed March 3, 2022)."},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0175","unstructured":"Guidance produced from the Expert Haematology Panel (EHP) focused on syndrome of thrombosis and thrombocytopenia occurring after coronavirus vaccination. London (UK): British Society for Haematology; 2021. Available: https:\/\/b-s-h.org.uk\/about-us\/news\/guidance-produced-by-the-expert-haematology-panel-ehp-focussed-on-vaccine-induced-thrombosis-and-thrombocytopenia-vitt\/ (accessed March 3, 2022)."},{"key":"10.1053\/j.seminhematol.2022.02.005_bib0176","doi-asserted-by":"crossref","unstructured":"Pai M, Chan B, Stall NM, et al.; Drugs & Biologics Clinical Practice Guidelines Working Group and the Ontario COVID-19 Science Advisory Table. Vaccine induced immune thrombotic thrombocytopenia (VITT) following adenovirus vector COVID-19 vaccination. Ontario: Ontario COVID-19 Science Advisory Table; 2021. Available: https:\/\/covid19-sciencetable.ca\/sciencebrief\/vaccine-induced-immune-thrombotic-thrombocytopenia-vitt-following-adenovirus-vector-covid-19-vaccination\/ (accessed March 3, 2022).","DOI":"10.47326\/ocsat.2021.02.17.2.0"},{"issue":"12","key":"10.1053\/j.seminhematol.2022.02.005_bib0177","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1055\/a-1585-6182","article-title":"Venous thromboembolism and mild thrombocytopenia after ChAdOx1 nCoV-1 vaccination","volume":"121","author":"Gabarin","year":"2021","journal-title":"Thromb Haemost"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196322000087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196322000087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:28:31Z","timestamp":1758522511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196322000087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":177,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0037196322000087"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2022.02.005","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet-activating anti-PF4 disorders: An overview","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2022.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}